NEUROONE MEDICAL TECHNOLOGIES Corp
NMTC· Nasdaq
NMTCNEUROONE MEDICAL TECHNOLOGIES Corp
Filed Dec 17, 2024 · 10-K · 78 days after period end · 0001213900-24-109524
derived · Computed from the longer spans the company filed.
| Metric | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021 |
|---|---|---|---|---|
| Revenue | $272.28K | $741.78K | $68.79K | $33.75K |
| Net Income | -$3.35M | -$3.14M | -$1.37M | -$2.81M |
| EPS Diluted | — | — |
NEUROONE MEDICAL TECHNOLOGIES Corp · CIK 1500198 · Engraved from SEC EDGAR
| — |
| -$0.18 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Sep 30, 2024 · filed Dec 17, 2024 · 78 d after period end
